Nanobiotix S.A. (NBTX:NASDAQ) closed at $26.50 on November 20, 2026, down 2.98% on the day. The stock trades 53.6% below its 52-week high of $57.14 and 38.5% above its 52-week low of $19.14. Over the past year, it gained 26.6%. Nanobiotix S.A. is part of the Health Care sector.
In 252 trading sessions since November 20, 2025, NBTX closed higher on 124 days (49%). Its best day was May 6, 2026 (+20.39%) and its worst was March 11, 2026 (-14.00%). The stock moved 10% or more in a single session 17 times. It opened at least 5% above the previous day's high 8 times.
Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its lead product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
Find more stocks like NBTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.